A quality reviewer gives the same raw data file from a peptide purity run to two experienced analysts and asks each to process it. One reports 98.7 percent. The other reports 98.4 percent. Nobody made an error, the instrument recorded one trace, and both analysts followed defensible practice. The difference comes from integration: the set of decisions that turns a detector signal into peak areas. Those decisions are rarely visible in a summary document, yet they sit directly between the chromatogram and the purity number.
Areas are constructed, not read
A chromatography data system does not simply measure peak areas. It first decides where each peak starts and ends, then projects a baseline underneath, then assigns the region between the signal and that baseline to a named peak. Parameters such as the expected peak width, the slope threshold that marks a peak start, and the minimum area worth reporting all feed that process. Change them and the areas change, even though the raw signal is untouched.
Area-percent purity is the main-peak area divided by the total integrated area. Anything that moves area between the main peak and its neighbors, or changes how much small-peak area is counted, moves the purity figure. The basics of what that figure represents are covered in reverse-phase HPLC and peptide purity.
Four decisions that move the number
| Decision | Typical effect on reported purity | What to look for in the trace |
|---|---|---|
| Shoulder on the main peak merged into it | Raises purity | An inflection or bulge on the leading or trailing edge |
| Drop-line split of an overlapping pair | Shares the overlap between the two peaks | Vertical lines from the valley to the baseline |
| Valley-to-valley baseline | Usually reduces the smaller peak’s area | Baseline segments drawn between adjacent valleys |
| Baseline projected high or low under drift | Shrinks or inflates small impurity areas | Where the drawn baseline meets a sloping signal |
The shoulder question
The most consequential single decision concerns a partly resolved impurity that shows up only as a bulge on the side of the main peak. It can be integrated as a separate peak, or it can be left inside the main peak. Leaving it in always raises purity. That outcome is seldom deliberate. More often the software applies its default settings, the default folds the bulge into the main peak, and no one reviews the result closely enough to override it.
A harder case is an impurity so poorly resolved that it creates no visible bulge. No integration convention can separate what the chromatography has not separated; every approach credits that material to the main peak. Finding it requires a change in the separation, a second detection technique, or a different method, not a different integration setting.
Splitting a valley: two conventions
When two peaks overlap partly, the area in the overlap has to be divided somehow. The drop-line approach draws a vertical line from the lowest point of the valley down to the baseline and assigns everything on each side to the peak on that side. It is simple and widely used, and it gives each peak some area that physically belongs to its neighbor.
The valley-to-valley approach instead draws the baseline from one valley point to the next, as though each peak sits on the tail of the adjacent one. It generally reduces the area assigned to the smaller peak.
Neither is correct in an absolute sense. Both are conventions, and a properly written method states which one it uses. With a sizeable impurity on the flank of the main peak, the choice alone can move reported purity by a few tenths of a percent, which is enough to explain the gap between the two analysts in the opening example.
Where the baseline goes
On a flat, quiet stretch of chromatogram, baseline placement is uncontroversial. Under a gradient, the signal often rises as the organic proportion of the mobile phase increases, and projecting the baseline under each peak becomes a real judgment. Set it slightly high and areas shrink; slightly low and they grow. For a tall, well-resolved main peak the effect is negligible. For a small impurity near the reporting threshold, it can decide whether the impurity is reported at all.
What this means for comparing figures
Integration variability is among the larger contributors to uncertainty in a reported purity. The practical consequence is that small differences between two purity figures, such as 98.4 and 98.7 percent, are rarely meaningful on their own, especially when they come from different laboratories, methods or processing settings. Reasons results differ between sources are discussed further in why suppliers report different peptide purity.
A trace is more informative than a number for the same reason. A percentage cannot be reprocessed; a chromatogram shown with its integration marks can be examined by anyone who wants to check where the peak boundaries and baseline were drawn. How to read an HPLC chromatogram walks through what to look for.
A review checklist for integrated chromatograms
- Are peak start and end markers and the baseline shown on the trace?
- Is any bulge or inflection on the main peak integrated separately, or merged?
- Where peaks overlap, does the method state drop-line or valley-to-valley?
- Does the baseline follow the signal sensibly across any gradient drift?
- Is there a stated reporting threshold for small peaks?
- Would reprocessing with the method’s stated parameters reproduce the reported figure?
Questions of this kind are also useful to put to a supplier; a list is collected in HPLC method questions for a peptide supplier. Battle Born publishes an independent reverse-phase HPLC result for each product, and the same integration principles apply to reading it.
What integration cannot touch
Integration governs proportions within a chromatogram. It does not establish identity: whether the main peak is the intended sequence is a separate question for mass or other identity techniques. It also has nothing to say about properties outside chromatography altogether. A purity figure, however carefully integrated, describes the relative size of peaks detected under one method’s conditions.
Questions
Why can two analysts get different purities from the same data?
Because peak boundaries, baseline placement and the handling of shoulders involve judgment and software settings. Different defensible choices give different areas.
Which integration convention is correct?
Neither drop-line nor valley-to-valley is correct in an absolute sense. A method should state which it uses and apply it consistently.
Does merging a shoulder raise or lower purity?
It raises it, because the impurity’s area is counted as part of the main peak.
How large a difference in purity is meaningful?
Differences of a few tenths of a percent are often within integration variability, particularly across laboratories or methods.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.